Pharming Group (Netherlands) Investor Sentiment

PHARM Stock  EUR 0.83  0.02  2.35%   
About 61% of Pharming Group's investor base is looking to short. The analysis of current outlook of investing in Pharming Group NV suggests that many traders are alarmed regarding Pharming Group's prospects. The current market sentiment, together with Pharming Group's historical and current headlines, can help investors time the market. In addition, many technical investors use Pharming Group NV stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
Jefferies Financial Group Initiates Coverage on Pharming Group - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Objective longshort Report - Stock Traders Daily
Google News at Macroaxis
over a week ago at news.google.com         
Pharming Group Sees Large Volume Increase - Heres Why - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Pharming Group Shares Gap Down - Heres What Happened - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group to participate in November investor conference - StockTitan
Google News at Macroaxis
over two months ago at news.google.com         
Pharming Group Shares Down 4.8 percent - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Pharming Group Shares Gap Down to 8.49 - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group to participate in September investor conferences - Yahoo Finance UK
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group Shares Down 4 percent - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
How the price action is used to our Advantage - Stock Traders Daily
Google News at Macroaxis
over three months ago at news.google.com         
Earnings call Pharming Group reports robust growth and pipeline expansion - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group Trading 4.1 percent Higher - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group Shares Gap Down to 8.96 - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group Shares Gap Up to 8.49 - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group Shares Down 6.4 percent - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharming Group that are available to investors today. That information is available publicly through Pharming media outlets and privately through word of mouth or via Pharming internal channels. However, regardless of the origin, that massive amount of Pharming data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharming Group news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharming Group relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharming Group's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharming Group alpha.

Pharming Group Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharming Stock analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators